IL20RB and colorectal carcinoma: The proposed integrated “ITH–immunity–prognosis” stratification framework offers a novel molecular rationale for precision subtyping and immunotherapeutic targeting in CRC, while establishing a mechanistic foundation for future IL20RB-focused clinical investigations.